Chronic Myeloproliferative Neoplasm Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Childhood Solid Tumor, Protocol SpecificInterventions: Drug: ruxolitinib phosphate; Other: laboratory biomarker analysis; Other: pharmacological studySponsors: Children's Oncology Group; National Cancer Institute (NCI)Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2010 Category: Research Source Type: clinical trials
Registry of Older Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders; Cognitive/Functional Effects; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol SpecificIntervention: Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2010 Category: Research Source Type: clinical trials
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Testicular Germ Cell TumorInterventions: Genetic: DNA analysis; Genetic: polymerase chain reaction; Other: flow cytometry; Other: laboratory biomarker analysisSponsors: Vanderbilt University; National Cancer Institute (NCI)Terminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2010 Category: Research Source Type: clinical trials
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Dietary Supplement: Lactobacillus rhamnosus GGSponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Dietary Supplement: Lactobacillus rhamnosus GGSponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Dietary Supplement: Lactobacillus rhamnosus GGSponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2009 Category: Research Source Type: clinical trials
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol SpecificIntervention: Device: 3'-deoxy-3'-[18F]fluorothymidineSponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2009 Category: Research Source Type: clinical trials